Displaying 680 results out of a total of 3930 publications.
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
Peng, X;Chen, Z;Farshidfar, F;Xu, X;Lorenzi, PL;Wang, Y;Cheng, F;Tan, L;Mojumdar, K;Du, D;Ge, Z;Li, J;Thomas, GV;Birsoy, K;Liu, L;Zhang, H;Zhao, Z;Marchand, C;Weinstein, JN;, ;Bathe, OF;Liang, H;
Cell Rep, Cell Rep 23(1):255-269.e4, 2018
View publication
Cell Rep, Cell Rep 23(1):255-269.e4, 2018
Anti-tumor effects of a 'human & mouse cross-reactive'anti-ADAM17 antibody in a pancreatic cancer model in vivo
Ye, J;Yuen, SM;Murphy, G;Xie, R;Kwok, HF;
European Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences ():, 2017
View publication
European Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences ():, 2017
Oncogenic -catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids
Riemer, P;Rydenfelt, M;Marks, M;van Eunen, K;Thedieck, K;Herrmann, BG;Blthgen, N;Sers, C;Morkel, M;
J. Cell Biol., J. Cell Biol. ():, 2017
View publication
J. Cell Biol., J. Cell Biol. ():, 2017
A novel method to generate T-cell receptor-deficient chimeric antigen receptor T cells
Kamiya, T;Wong, D;Png, YT;Campana, D;
Blood Adv, Blood Adv 2(5):517-528, 2018
View publication
Blood Adv, Blood Adv 2(5):517-528, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Ambrogio, C;Khler, J;Zhou, ZW;Wang, H;Paranal, R;Li, J;Capelletti, M;Caffarra, C;Li, S;Lv, Q;Gondi, S;Hunter, JC;Lu, J;Chiarle, R;Santamara, D;Westover, KD;Jnne, PA;
Cell, Cell ():, 2018
View publication
Cell, Cell ():, 2018
Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions
Rajasekaran, N;Jung, HS;Bae, SH;Chelakkot, C;Hong, S;Choi, JS;Yim, DS;Oh, YK;Choi, YL;Shin, YK;
Neoplasia, Neoplasia 19(10):735-749, 2017
View publication
Neoplasia, Neoplasia 19(10):735-749, 2017
Cellular senescence is a central response to cytotoxic chemotherapy in high-grade serous ovarian cancer
Calvo, L;Cheng, S;Skulimowski, M;Clement, I;Portelance, L;Zhan, Y;Carmona, E;Lafontaine, J;de Ladurantaye, M;Rahimi, K;Provencher, D;Mes-Masson, A;Rodier, F;
bioRxiv, bioRxiv ():, 2018
View publication
bioRxiv, bioRxiv ():, 2018
CuATSM protects against the in vitro cytotoxicity of wild type-like SOD1 mutants but not mutants that disrupt metal binding
Farrawell, NE;Yerbury, MR;Plotkin, SS;McAlary, L;Yerbury, JJ;
ACS Chem Neurosci, ACS Chem Neurosci ():, 2018
View publication
ACS Chem Neurosci, ACS Chem Neurosci ():, 2018
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma
Miikkulainen, P;Hgel, H;Seyednasrollah, F;Rantanen, K;Elo, LL;Jaakkola, PM;
J. Biol. Chem., J. Biol. Chem. ():, 2019
View publication
J. Biol. Chem., J. Biol. Chem. ():, 2019
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
Wang, L;Leite de Oliveira, R;Huijberts, S;Bosdriesz, E;Pencheva, N;Brunen, D;Bosma, A;Song, JY;Zevenhoven, J;Los-de Vries, GT;Horlings, H;Nuijen, B;Beijnen, JH;Schellens, JHM;Bernards, R;
Cell, Cell 173(6):1413-1425.e14, 2018
View publication
Cell, Cell 173(6):1413-1425.e14, 2018